Opt Creation

Opt Creation Inc. (オプトクリエーション) is a Japan-based life sciences company that has developed proprietary ozone nanobubble technology — a method that dissolves ozone gas in nanobubbles for long-term stable storage. The company applies this technology across multiple healthcare verticals, including the development of new anti-cancer treatments in R&D, as well as consumer health products such as soft drinks and cosmetics. Opt Creation has received backing from TEL Venture Capital and is expanding its ozone nanobubble applications globally. The company is noted as having exited (per its original DB description), consistent with its TEL VC portfolio listing.